The estimated Net Worth of Asset Management Lpweiss An... is at least $22.3 millió dollars as of 29 September 2020. Asset An owns over 100,000 units of KBL Merger IV stock worth over $21,058,074 and over the last 8 years Asset sold KBLM stock worth over $1,274,000.
Sign up
Asset An KBLM stock SEC Form 4 insiders trading
Asset has made over 1 trades of the KBL Merger IV stock since 2020, according to the Form 4 filled with the SEC. Most recently Asset sold 100,000 units of KBLM stock worth $1,274,000 on 29 September 2020.
The largest trade Asset's ever made was selling 100,000 units of KBL Merger IV stock on 29 September 2020 worth over $1,274,000. On average, Asset trades about 20,000 units every 0 days since 2016. As of 29 September 2020 Asset still owns at least 4,220,055 units of KBL Merger IV stock.
You can see the complete history of Asset An stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at KBL Merger IV
Over the last 7 years, insiders at KBL Merger IV have traded over $12,807,331 worth of KBL Merger IV stock. The most active insiders traders include Asset Management Partners I..., Asset Management Llp Oxford és Securities Usa Llc Mizuho. On average, KBL Merger IV executives and independent directors trade stock every 52 days with the average trade being worth of $380,652. The most recent stock trade was executed by Asset Management Llp Oxford on 9 October 2019, trading 699,900 units of KBLM stock currently worth $7,355,949.
What does KBL Merger IV do?
KBL Merger Corp. IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal reimbursement risk the firm focuses on retail healthcare, wellness and preventative care. In devices and diagnostics the firm focuses on medical devices, diagnostics, genetic testing and lab tools. The firm typically invests in firms located in the United States. The firm seeks to invest in firms with valuation between $200 million to $700 million and EBITDA between $20 million to $70 million. The firms invest in firms with enterprise value $200 million to $700 million. The firm seeks to take majority stakes. KBL Merger Corp. IV was founded in 2016 and is New York, New York with an additional office in Newark, Delaware.
What does KBL Merger IV's logo look like?
Complete history of Asset An stock trades at Pfenex és KBL Merger IV
KBL Merger IV executives and stock owners
KBL Merger IV executives and other stock owners filed with the SEC include:
-
Shoshana Shendelman,
Director -
Donald McGovern,
Director -
Larry Gold,
Director -
Richard Barker,
Director -
Jonathan Rothbard,
Chief Scientific Officer -
James Woody,
Chief Executive Officer, Director -
Lawrence Steinman,
Co-Executive Chairmen of the Board -
Marc Feldmann,
Co-Executive Chairman of the Board -
Asset Management Llp Oxford,
10% owner -
Asset Management Lpweiss An...,
-
Securities Usa Llc Mizuho,
10% owner -
Asset Management Partners I...,
10% owner